JPH0240067B2 - - Google Patents

Info

Publication number
JPH0240067B2
JPH0240067B2 JP59104257A JP10425784A JPH0240067B2 JP H0240067 B2 JPH0240067 B2 JP H0240067B2 JP 59104257 A JP59104257 A JP 59104257A JP 10425784 A JP10425784 A JP 10425784A JP H0240067 B2 JPH0240067 B2 JP H0240067B2
Authority
JP
Japan
Prior art keywords
methyl
pyrimidine
dihydroimidazo
carboxylate
nitrophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59104257A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60246387A (ja
Inventor
Nobunao Tsuda
Tadashi Mishina
Minoru Obata
Atsushi Inui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Yoshitomi Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical Industries Ltd filed Critical Yoshitomi Pharmaceutical Industries Ltd
Priority to JP59104257A priority Critical patent/JPS60246387A/ja
Priority to CA000481703A priority patent/CA1271751A/en
Priority to EP85106208A priority patent/EP0163240A3/en
Priority to KR1019850003488A priority patent/KR850008488A/ko
Priority to ES543361A priority patent/ES8706683A1/es
Publication of JPS60246387A publication Critical patent/JPS60246387A/ja
Priority to US07/154,398 priority patent/US4918074A/en
Publication of JPH0240067B2 publication Critical patent/JPH0240067B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP59104257A 1984-03-12 1984-05-22 ジヒドロイミダゾ〔１，２−ａ〕ピリミジン誘導体 Granted JPS60246387A (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP59104257A JPS60246387A (ja) 1984-05-22 1984-05-22 ジヒドロイミダゾ〔１，２−ａ〕ピリミジン誘導体
CA000481703A CA1271751A (en) 1984-05-22 1985-05-16 Dihydroimidazo[1,2-a]pyrimidine derivatives
EP85106208A EP0163240A3 (en) 1984-05-22 1985-05-21 Dihydroimidazo[1,2-a]pyrimidine derivatives, methods of preparing said compounds and pharmaceutical compositions constaining said compounds
KR1019850003488A KR850008488A (ko) 1984-05-22 1985-05-21 디히드로이미다조 [1,2-a] 피리미딘 유도체류의 제조방법
ES543361A ES8706683A1 (es) 1984-05-22 1985-05-21 Metodo para preparar un derivado de dihidroimidazo(1,2-a)pi-rimidina
US07/154,398 US4918074A (en) 1984-03-12 1988-02-10 Polyazaheterocycle compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59104257A JPS60246387A (ja) 1984-05-22 1984-05-22 ジヒドロイミダゾ〔１，２−ａ〕ピリミジン誘導体

Publications (2)

Publication Number Publication Date
JPS60246387A JPS60246387A (ja) 1985-12-06
JPH0240067B2 true JPH0240067B2 (en, 2012) 1990-09-10

Family

ID=14375875

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59104257A Granted JPS60246387A (ja) 1984-03-12 1984-05-22 ジヒドロイミダゾ〔１，２−ａ〕ピリミジン誘導体

Country Status (5)

Country Link
EP (1) EP0163240A3 (en, 2012)
JP (1) JPS60246387A (en, 2012)
KR (1) KR850008488A (en, 2012)
CA (1) CA1271751A (en, 2012)
ES (1) ES8706683A1 (en, 2012)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918074A (en) * 1984-03-12 1990-04-17 Yoshitomi Pharmaceutical Industries, Ltd. Polyazaheterocycle compounds
EP0217142A3 (en) * 1985-09-30 1988-01-07 Yoshitomi Pharmaceutical Industries, Ltd. A polyazaheterocyclic compound
US4746656A (en) * 1986-07-21 1988-05-24 E. R. Squibb & Sons, Inc. 1,2,4,7-tetrahydro-2-oxopyrazolo[1,5-a]pyrimidine derivatives
US4883872A (en) * 1987-11-25 1989-11-28 E. R. Squibb & Sons, Inc. 3-oxo-1,2,4-triazolo(4,3-A) pyrimidine-6-carboxylic acid esters
US4859676A (en) * 1988-01-19 1989-08-22 E. R. Squibb & Sons, Inc. 2-Oxo-1-sulfonyl pyrazolo(1,5-a) pyrimidine-6-carboxylic acid esters
US4870072A (en) * 1988-01-19 1989-09-26 E. R. Squibb & Sons, Inc. 2-oxo-1-substituted pyrazolo[1,5-A]pyrimidine-6-carboxylic acid esters as blood pressure reducing agents
GB8905130D0 (en) * 1989-03-07 1989-04-19 Pfizer Ltd Therapeutic agents
US6194419B1 (en) 1997-12-26 2001-02-27 Takeda Chemical Industries, Ltd. Nitrogen-containing heterocyclic compounds, their production and use
MY125533A (en) 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
US7772232B2 (en) 2004-04-15 2010-08-10 Bristol-Myers Squibb Company Quinazolinyl compounds as inhibitors of potassium channel function
EP1881986A2 (en) * 2005-05-12 2008-01-30 Merck & Co., Inc. Tyrosine kinase inhibitors
PE20121506A1 (es) * 2006-07-14 2012-11-26 Amgen Inc Compuestos triazolopiridinas como inhibidores de c-met
US8217177B2 (en) 2006-07-14 2012-07-10 Amgen Inc. Fused heterocyclic derivatives and methods of use
US20090012103A1 (en) 2007-07-05 2009-01-08 Matthew Abelman Substituted heterocyclic compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3244717A (en) * 1964-06-18 1966-04-05 Searle & Co 5-hydroxy-2-methyl-7-phenylimidazo [1, 2-a] pyrimidines
DE3234684A1 (de) * 1982-09-18 1984-03-22 Bayer Ag, 5090 Leverkusen Neue dihydropyrimidine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
JPS5965089A (ja) * 1982-10-05 1984-04-13 Shionogi & Co Ltd ジヒドロピラゾロ〔３，４−ｂ〕ピリジン誘導体およびその製造法

Also Published As

Publication number Publication date
ES543361A0 (es) 1987-07-01
EP0163240A2 (en) 1985-12-04
KR850008488A (ko) 1985-12-18
JPS60246387A (ja) 1985-12-06
ES8706683A1 (es) 1987-07-01
CA1271751A (en) 1990-07-17
EP0163240A3 (en) 1987-04-22

Similar Documents

Publication Publication Date Title
JPH0240067B2 (en, 2012)
AU2004255924A1 (en) Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases
AU708809B2 (en) 6-aryl pyrazolo{3,4-d}pyrimidin-4-ones and compositions and methods of use thereof
JP2753659B2 (ja) ピラゾール誘導体
EP0183848B1 (en) Polyazaheterocyclic derivatives, process for their preparation, and pharmaceutical composition
EP0217142A2 (en) A polyazaheterocyclic compound
US5387747A (en) Triazolopyrimidine derivatives which are angiotensin II receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present
US4912104A (en) Tricyclic fused pryimidine derivatives, and their use as pharmaceuticals
US4588720A (en) Imidazo[1,2-a]pyrimidines
US4002755A (en) Triazoloquinazolines
SK99794A3 (en) Triazolopyrimidine derivatives as antiotensin ii receptor antagonists, method of their preparation, pharmaceutical agent and use
EP1248787B1 (en) NOVEL SUBTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM
JPH05132484A (ja) ピラゾロキノリン及びピラゾロナフチリジン誘導体
US4703049A (en) 2-(1,2,4-oxadiazol-5-yl) and 2-(1,3,4-thiadiazol-2-yl-imidazo[1,2-a]pyrimidines
US3764600A (en) 1-substituted-quinazoline-2(1h)-thiones
KR920000271B1 (ko) 1,2,4-트리아조로[1,5-c] 피리미딘 및 이의 제조방법
Bishop et al. Synthesis and reactions of [1, 2, 4] triazolo [1, 5-a] pyrimidinium-2-aminides
US4591588A (en) Triazolo[1,5-c]pyrimidines and bronchodilation use thereof
US4028356A (en) Triazinobenzodiazepines
JPS61227584A (ja) ポリアザ複素環誘導体
EP0013914B1 (en) Piperazinyl-imidazo(1,2-a)pyrazine derivatives, process for their preparation and pharmaceutical compositions containing them
JPS59170091A (ja) ６−チオ−７−デアザプリン誘導体およびその製造法
JPS58427B2 (ja) ４−（ピリジンカルボニル）フェニル−１，２，４−トリアゾ−ル誘導体の製造法
US3481928A (en) 1,2-dihydro-4-hydroxy-quinazolino-3-oxides
Mekonnen et al. Electrophilic substitution of imidazo [2, 1-b] oxazoles